Found 2 bookmarks
Custom sorting
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases

Up to 70% of SARS-CoV-2 infected have reduced organ function for 4 months or more after infection, which leads to an increased risk of developing chronic diseases in e.g. lungs, kidneys and the cardiovascular system.

“Even though the etiology of COVID-19 is complex and there are multiple factors involved, decreased organ function has been associated with mitochondrial dysfunction for both the acute phase and post-acute phase of COVID”

·nature.com·
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Novel biomarkers of mitochondrial dysfunction in Long COVID patients
Novel biomarkers of mitochondrial dysfunction in Long COVID patients

New study on changes in mitochondria in Long Covid.

1️⃣Increased ROS (super oxide dismutase 1), … note Taurine can help counteract 2️⃣changes in mito recycling (mitophagy) and 3️⃣a potential biomarker: lower amounts of circulating free mito dna… could be used as a test

·link.springer.com·
Novel biomarkers of mitochondrial dysfunction in Long COVID patients